Sarcoma  >>  BI-1  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI-1 / Boehringer Ingelheim
NCT02159443: Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody

Completed
N/A
76
US
St. Jude Children's Research Hospital, University of Wisconsin, Madison
Ewing Family of Tumors, Melanoma, Neuroblastoma, Osteosarcoma
10/19
04/20

Download Options